Chemung Financial (CMHG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Oct, 2025Executive summary
Net income for Q2 2024 was $5.0 million ($1.05 per share), down 21% year-over-year and from $7.1 million in Q1 2024, with a return on average equity of 10.27% and return on average assets of 0.73%.
Six-month net income was $12.0 million ($2.53 per share), down 11% from the prior year, mainly due to lower net interest income and higher non-interest expense.
Commercial credit pipelines remain robust, especially in the Capital District and Western NY.
Funding costs continue to challenge net interest income expansion despite loan growth.
Focus remains on expense management and branch rationalization.
Financial highlights
Net interest income for Q2 2024 was $17.8 million, down 4.5% year-over-year and 1.7% sequentially, driven by higher deposit and borrowing costs.
Non-interest income was $5.6 million, up 2.8% year-over-year and 3.7% year-over-year, but down 1.8% sequentially, led by higher wealth management fees and equity investment gains.
Non-interest expense was $16.2 million, up 1.9% year-over-year but down 3.0% sequentially, with compensation and benefits up 4%.
Efficiency ratio (adjusted) was 69.19% for Q2 2024, up from 65.94% a year ago but improved from 70.07% in Q1 2024.
Allowance for credit losses was $21.0 million (1.05% of loans), with net charge-offs of $0.3 million in Q2.
Outlook and guidance
Management expects continued pressure on net interest margin due to competition for deposits and higher funding costs.
Loan growth is anticipated to remain concentrated in commercial real estate, especially in the Albany and Western NY regions.
Asset quality remains stable, but management is monitoring economic conditions and credit trends closely.
Management continues to monitor the impact of elevated interest rates on borrowers.
The company anticipates continued use of brokered deposits as a secondary funding source.
Latest events from Chemung Financial
- All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025 - Adjusted net income reached $6.3M as capital moves offset a $17.5M securities loss.CMHG
Q2 20257 Aug 2025 - Q3 2024 net income fell year-over-year as higher costs offset loan growth and margin stability.CMHG
Q3 202413 Jun 2025 - 2024 net income fell 5.3% to $23.7M as higher expenses offset loan growth.CMHG
Q4 20249 Jun 2025